ArticleEClinicalMedicine2026

Efficacy, safety, and completion of modified short-course rifapentine and isoniazid for latent tuberculosis infection in patients with high-risk rheumatic disease: a multicentre, open-label, randomized, non-inferiority trial.

Lifan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.